Operating cash flow of $156.6M in 2026Q2 exceeded net income (OCF/NI of 1.24), fully covering $77.6M in dividends and buybacks, but net investment outflows of $600M in the quarter may indicate reliance on portfolio turnover to sustain yields.
CNO Financial Group, Inc. (CNO) cash flow statement — 24-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Cash from Operations | 698.9M | 675.7M | 627.7M | 582.9M | 495.4M | 598.3M | 735.5M | 696.7M | 317.8M | 613.1M | 759.5M | 743.9M | 121.8M | 720.4M | 634.9M | 774.8M | 734M | 644M | 986.8M | 703.3M | 931.2M | 1.16B | 1.05B | 1.19B | 1.3B |
| Operating CF Growth % | 4.49% | 7.65% | 7.69% | 17.66% | -17.2% | -18.65% | 5.57% | 119.23% | -48.17% | -19.28% | 2.1% | 510.76% | -83.09% | 13.47% | -18.06% | 5.56% | 13.98% | -34.74% | 40.31% | -24.47% | -19.87% | 10.93% | -11.7% | -8.44% | - |
| Operating CF / Revenue % | 15.04% | 15.06% | 14.12% | 14.06% | 13.85% | 14.51% | 19.25% | 17.35% | 7.37% | 14.25% | 19.02% | 19.57% | 2.94% | 16.09% | 14.62% | 18.78% | 17.97% | 14.83% | 23.55% | 17.02% | 20.84% | 26.86% | 24.17% | 25.19% | 29.11% |
| Net Income | 279.6M | 229.3M | 404M | 276.5M | 630.6M | 570.3M | 301.8M | 278M | -315M | 175.6M | 358.2M | 270.7M | 51.4M | 478M | 221M | 382.5M | 284.6M | 85.7M | -1.13B | -179.9M | 96.5M | 324.9M | 294.8M | 0 | 0 |
| Depreciation & Amortization | 161.9M | 318.5M | 292.4M | 267.4M | 248.5M | 236.6M | 303.9M | 267.9M | 292.2M | 265.4M | 275M | 283.4M | 274.2M | 324.6M | 315M | 458.6M | 465.3M | 460.9M | 412M | 483.2M | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 25.2M | 0 | 18.8M | 24.7M | 21.4M | 23M | 17.1M | 15.6M | 15.1M | 15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -6M | 26.3M | 59.1M | 21.1M | 152M | 146.5M | 14.1M | -132.8M | 18.4M | 227.5M | -11.7M | 92.9M | 119.7M | -181.2M | -71.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 74.6M | -516.5M | -684.1M | -431.8M | -161M | -726.5M | -281.9M | -367.6M | 728.2M | -233.7M | -19.2M | 9.3M | -682M | -110.4M | 113.5M | -41.8M | 18.2M | 115M | 1.26B | -315.1M | 1.32B | 1.24B | 1.12B | 1.07B | 0 |
| Working Capital Changes | 352.4M | 618.1M | 556.3M | 449.7M | -374.7M | 346.2M | 397.6M | 632.4M | 207.8M | 464.7M | 332.8M | 297.4M | 398.2M | 465.8M | 330M | -24.5M | -34.1M | -17.6M | 437.5M | 715.1M | -484.7M | -400.9M | -364.4M | 115.7M | 0 |
| Cash from Investing | -1.79B | -1.67B | -1.49B | -872.3M | -1.78B | -1.53B | -608.4M | -555.6M | -525.7M | -239.6M | -742.4M | -1.07B | 56.3M | -602.5M | -197.1M | -1.34B | -1.3B | -922.7M | -629.8M | -1.13B | -1.05B | -1.55B | -1.46B | 422.5M | 3.41B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 231M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -13.92B | -8.46B | -6.89B | -3.62B | -6.52B | -6.15B | -4.28B | -5.59B | -6.21B | -6.14B | -6.24B | -4.78B | -3.73B | -5.37B | -4.27B | -8.16B | -10.74B | -12.54B | -8.19B | -9.25B | -9.49B | -14.45B | -16B | -12.98B | -27.76B |
| Sale/Maturity of Investments | 12.13B | 6.8B | 5.42B | 2.79B | 4.8B | 4.7B | 3.71B | 5.14B | 5.71B | 5.92B | 5.35B | 4.03B | 3.71B | 4.84B | 4.09B | 6.9B | 9.53B | 11.63B | 7.53B | 8.14B | 9.5B | 12.94B | 14.6B | 13.42B | 31.76B |
| Other Investing | -4M | -3.2M | -13.5M | -36.6M | -61.2M | -75.3M | -39.8M | -102M | -25M | -19.5M | 152.6M | -321.1M | -156.2M | -73.1M | -11.4M | -80.1M | -86M | -9.2M | 36.1M | -21.3M | -1.06B | -31.6M | -57.6M | -18.2M | -589.9M |
| Cash from Financing | 1.59B | -22.6M | 1.97B | 533.5M | 1.2B | 667.6M | 210.1M | -143M | 107.2M | -274M | 26.2M | 146.4M | -265.5M | -1.4M | -291.3M | 427.3M | 613.1M | -92.4M | 175.6M | 447M | 268.1M | -150.2M | -44.4M | -1.6B | -6.5B |
| Dividends Paid | -66.4M | -66.2M | -67.7M | -68.1M | -64.8M | -65.7M | -67M | -67.1M | -64.8M | -59.6M | -54.8M | -52M | -51M | -24.4M | -13.9M | 0 | 0 | 0 | 0 | -19M | -38M | -38M | -19.3M | 0 | -86.2M |
| Share Repurchases | -255M | -331.4M | -300.2M | -166.1M | -190.1M | -407.8M | -268.3M | -254.5M | -108M | -168.3M | -210M | -365.4M | -376.5M | -118.4M | -180.2M | -69.8M | 0 | 0 | 0 | -87.2M | 0 | 0 | -928.9M | 0 | 0 |
| Stock Issued | 11.1M | 11.6M | 11.2M | 13.2M | 13.5M | 21.5M | 19M | 9.2M | 3.9M | 8.3M | 8.4M | 6.3M | 5M | 15.1M | 3.1M | 2.2M | 0 | 296.3M | 0 | 3.4M | 1M | 500K | 882.2M | 0 | 0 |
| Debt Issuance (Net) | 900K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -100K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K | 1000K | 1000K | -1000K | 0 | -1000K |
| Other Financing | 1.47B | 833M | 1.96B | 495.8M | 1.56B | 1.05B | 384.5M | 379.2M | 276.2M | 213.3M | 205.1M | -4.8M | -52.5M | -240.5M | -248.2M | 29.2M | 25.7M | -1.2M | 290.1M | -137.1M | 156.4M | -196M | -3.6M | -1.6B | -2.6B |
| Net Change in Cash | 490M | -1.01B | 1.11B | 244.1M | -86.8M | -260.2M | 337.2M | -1.9M | -100.7M | 99.5M | 46.6M | -179.3M | -87.4M | 116.5M | 146.5M | -135.9M | 48.5M | -371.1M | 532.6M | 21.6M | 148.1M | -538.8M | -452.1M | 11.1M | -1.79B |
| Exchange Rate Effect | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 1.15B | 2B | 889M | 644.9M | 731.7M | 991.9M | 654.7M | 656.6M | 757.3M | 478.9M | 432.3M | 611.6M | 699M | 582.5M | 436M | 571.9M | 523.4M | 894.5M | 361.9M | 385.9M | 237.8M | 776.6M | 1.23B | 2.38B | 3.01B |
| Cash at End | 1.31B | 983.5M | 2B | 889M | 644.9M | 731.7M | 991.9M | 654.7M | 656.6M | 578.4M | 478.9M | 432.3M | 611.6M | 699M | 582.5M | 436M | 571.9M | 523.4M | 894.5M | 407.5M | 385.9M | 237.8M | 776.6M | 2.39B | 1.22B |
| Free Cash Flow | 698.9M | 675.7M | 627.7M | 582.9M | 495.4M | 598.3M | 735.5M | 696.7M | 317.8M | 613.1M | 759.5M | 743.9M | 121.8M | 720.4M | 634.9M | 774.8M | 734M | 644M | 986.8M | 703.3M | 931.2M | 1.16B | 1.05B | 1.19B | 1.3B |
| FCF Growth % | -0.78% | 7.65% | 7.69% | 17.66% | -17.2% | -18.65% | 5.57% | 119.23% | -48.17% | -19.28% | 2.1% | 510.76% | -83.09% | 13.47% | -18.06% | 5.56% | 13.98% | -34.74% | 40.31% | -24.47% | -19.87% | 10.93% | -11.7% | -8.44% | - |
| FCF Margin % | 15.04% | 15.06% | 14.12% | 14.06% | 13.85% | 14.51% | 19.25% | 17.35% | 7.37% | 14.25% | 19.02% | 19.57% | 2.94% | 16.09% | 14.62% | 18.78% | 17.97% | 14.83% | 23.55% | 17.02% | 20.84% | 26.86% | 24.17% | 25.19% | 29.11% |
| FCF per Share | 7.36 | 6.91 | 5.81 | 5.06 | 4.21 | 4.56 | 5.14 | 4.43 | 1.92 | 3.56 | 4.26 | 3.81 | 0.56 | 3.1 | 2.26 | 2.55 | 2.43 | 3.33 | 5.34 | 4.06 | 6.11 | 6.28 | 7.2 | 11.85 | 12.94 |
Quick answers to the most common questions about buying CNO stock.
CNO Financial Group, Inc. (CNO) generated $675.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
CNO Financial Group, Inc. (CNO) generated $675.7M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
CNO Financial Group, Inc. (CNO) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, CNO Financial Group, Inc. (CNO) returned $66.2M to shareholders via cash dividends and spent $331.4M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Regulatory scrutiny on Medicare marketing
Metrics are mathematically derived from official filings.
Underwriting Cash Generation Strengthens
CNO's operating cash flow reached $156.6M in 2026Q2, up from $110.9M a year earlier, as reported in financial statements, indicating improved premium collection efficiency and claims management.
The OCF/NI ratio of 1.24 in 2026Q2, though lower than the unusually high 3.95 in 2026Q1, still indicates that cash generation exceeds net income, suggesting strong underwriting cash conversion. The consistent positive OCF across quarters, even when net income dipped to $9.3M in 2024Q3, underscores the stability of premium inflows relative to claims outflows. This pattern implies that CNO's core insurance operations are generating sufficient cash to cover claims and expenses, with the recent earnings beat likely supported by this cash flow strength.
Claims Payments Reflect Seasonality
Claims and loss payments averaged $660M per quarter over the last five quarters, with 2026Q2 at $727.2M, as per SEC filings, suggesting a rising trend that may pressure underwriting cash flows.
The increase in claims payments from $570.1M in 2026Q1 to $727.2M in 2026Q2, a 27.5% jump, appears to align with seasonal patterns observed in prior years, such as the spike in 2024Q3. However, the magnitude of the recent increase warrants monitoring, as it could indicate emerging morbidity trends in the legacy LTC block or higher utilization in supplemental health products. If claims continue to escalate without corresponding premium growth, the underwriting cash surplus could narrow, potentially affecting the company's ability to fund investment activities.
Investment Portfolio Churn Intensifies
Investment purchases outpaced sales by $600M in 2026Q2, with purchases at $4.3B and sales at $3.7B, as reported in financial statements, indicating active portfolio repositioning to capture higher yields.
The net investment outflow of $600M in 2026Q2, compared to a net inflow of $100M in 2026Q1, suggests that CNO is aggressively deploying cash into higher-yielding assets, likely in response to the higher-for-longer rate environment. This strategy appears to be enhancing the net investment spread, which is a key driver of profitability, as noted in company intelligence. However, the scale of purchases relative to sales also implies significant transaction costs and potential liquidity needs, which investors should monitor for impact on overall cash reserves.
Capital Returns Covered by Cash Flow
Dividends and buybacks totaled $77.6M in 2026Q2, fully covered by operating cash flow of $156.6M, as per recent earnings reports, indicating a sustainable capital return policy.
The payout ratio of approximately 50% of OCF in 2026Q2, consistent with prior quarters, suggests that CNO's capital returns are comfortably supported by underwriting cash generation, without relying on portfolio liquidation. The reduction in buybacks from $110.3M in 2025Q1 to $60.9M in 2026Q2 may reflect management's preference for redeploying capital into investment opportunities, but it still demonstrates a commitment to returning cash to shareholders. Given the stable OCF trend, the dividend appears secure, though investors should watch for any deviation in this coverage ratio.
Cash Earnings Outpace Reported Net Income
Operating cash flow exceeded net income in every quarter of the last two years, with OCF/NI ratios ranging from 0.84 to 24.86, as reported in SEC filings, indicating significant non-cash accruals in earnings.
The persistently higher OCF relative to net income, particularly in quarters like 2024Q3 (OCF/NI of 24.86), suggests that reported earnings are heavily influenced by non-cash items such as reserve releases and actuarial adjustments under LDTI. This divergence implies that cash generation is more stable than net income, which is prone to volatility from assumption changes. Investors should focus on OCF as a more reliable indicator of underlying performance, while recognizing that the gap may narrow as reserve releases taper off.
What Cash Flow Obscures
Despite strong operating cash flow, the $600M net investment outflow in 2026Q2, as per financial statements, may indicate a reliance on portfolio turnover to sustain yields, warranting scrutiny.
The cash flow statement reveals that CNO is actively managing its investment portfolio, but the large purchases and sales could mask underlying liquidity needs or a shift in asset allocation. Additionally, the claims payment trend, which rose to $727.2M in 2026Q2, may signal emerging pressure on underwriting cash flows that is not yet reflected in net income due to reserve releases. Investors should monitor whether the investment spread gains are sufficient to offset any deterioration in claims experience, as the cash flow data alone does not capture the credit risk of reinsurance recoverables or the potential for catastrophe-related losses.